News

Hosted on MSN2mon
Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol?
AstraZeneca said Monday its experimental pill ... This isn't the first time PCSK9 blockers have been in the limelight. Makar expects the daily pills to have an easier commercial time.
Business Wire1y
AstraZeneca announces initiation of THARROS – a Phase III clinical trial investigating the potential of BREZTRI to improve cardiopulmonary outcomes in people with COPD
--(BUSINESS WIRE)--AstraZeneca today announced the initiation ... diuretics (may potentiate hypokalemia and/or ECG changes) Beta-blockers (may block bronchodilatory effects of beta-agonists ...
CBS News2y
AstraZeneca says new COVID drug could guard against all variants of concern to date
A replacement for a key COVID-19 antibody drug that has been used to protect immunocompromised Americans could be available within months, executives for drugmaker AstraZeneca said Thursday ...
Forbes1y
AstraZeneca Paying Up To $2 Billion For Experimental Obesity Pill—As Weight Loss Drug Market Grows
AstraZeneca has agreed to pay up to $2 billion for an experimental pill used to treat obesity and type 2 diabetes—the latest pharmaceutical firm to bet on treatment similar to popular weight ...